20.2.2006 | Press monitoring
Farmers grew biotech crops in 21 countries in 2005 – including Spain and Canada. In a new video webcast at biotech-gmo.com, Pedro Lerín and Lorne Hamblin each candidly discuss the impact that biotech crops have had on their operations during the last six to eight years.
20.2.2006 | Press monitoring
Tissue engineering and cell therapy research has been taking place for some 25 years, but to date relatively few products have reached the market. Comprising bioengineered products, cell therapy and gene therapy, tissue engineering (TE) can be considered a healthcare industry sub-sector combining elements of the biotechnology,...
20.2.2006 | Press monitoring
Realizing the potential of agricultural genomics into practical applications requires quantitative predictions for complex traits and different genotypes and environmental conditions.
20.2.2006 | Press monitoring
Scientists from National Institute of Standards and Technology in Gaithersburg (USA) created long polymer nanotubes by directly pulling on the membrane of polymersomes using either optical tweezers or a micropipette. The polymersomes are composed of amphiphilic diblock copolymers, and the nanotubes formed have an aqueous core connected to the...
20.2.2006 | Press monitoring
Long before the first introduction of GM crops, international organizations like the Food and Agriculture Organization (FAO), World Health Organization (WHO), and Organization for Economic Co-operation and Development (OECD), had been promoting international consensus on how to assess the safety of such crops. An internationally harmonized...
20.2.2006 | Press monitoring
A new vaccine against one of the most common ailments of childhood won federal approval on 3rd February 2006, six years after a similar vaccine was pulled from the market for injuring scores of babies.
20.2.2006 | Press monitoring
After lung injury and damage to the alveolar epithelium, the underlying basement membranes become exposed. Proliferation of type II pneumocytes and their differentiation to the type I phenotype have been considered to be the mechanism by which repopulation of the alveolar epithelium occurs. A growing body of evidence has shown that tissues can...
20.2.2006 | Press monitoring
Production of recombinant human erythropoietin (rhEPO) for therapeutic purposes relies on its expression in selected clones of transfected mammalian cells. Alternatively, this glycoprotein can be produced by targeted secretion into the body fluid of transgenic mammals.
16.2.2006 | Press monitoring
Tobacco plants can now produce vaccine against Lyme disease - a tick-borne disease from the bacterium Borreliosis. Dr. Heribert Warzecha, from the University of Wuerzburg, Germany, describes how his group was able to accomplish this feat in the scientific journal Nature Biotechnology.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
OECD Biotechnology Topic - Organisation for Economic Co-operation and Development
Biotechnology - Biotechnology channel at Nature.com
Designing long-lived peptides for more powerful medicines
Team develops the first cell-free system in which genetic information and metabolism work together